Drug
R744
R744 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
6
100%
Phase Distribution
0
Early Stage
0
Mid Stage
6
Late Stage
Phase Distribution6 total trials
Phase 3Large-scale testing
6(100.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 36 (100.0%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_3
Clinical Study of R744 to Predialysis Patients
NCT00433615
completedphase_3
Correction Study of R744 in Renal Anemia Patients on Hemodialysis
NCT00433693
completedphase_3
Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study)
NCT00433888
completedphase_3
Clinical Study of R744 to Hemodialysis Patients
NCT00491868
completedphase_3
Clinical Study of R744 to Peritoneal Dialysis Patients
NCT00433849
Clinical Trials (6)
Showing 6 of 6 trials
NCT00433615Phase 3
Clinical Study of R744 to Predialysis Patients
NCT00433693Phase 3
Correction Study of R744 in Renal Anemia Patients on Hemodialysis
NCT00433888Phase 3
Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study)
NCT00491868Phase 3
Clinical Study of R744 to Hemodialysis Patients
NCT00433849Phase 3
Clinical Study of R744 to Peritoneal Dialysis Patients
NCT00492427Phase 3
Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta)
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6